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Background: Very little is known about human rotaviruses in the northwest of China. To
investigate the genomic diversity, we evaluated the distribution of rotavirus genotypes in this
region covering a 10-year period (1996—2005).
Methods: Rotavirus antigen was detected in stool specimens by enzyme immunoassay (EIA), and
G and P genotyping was performed by reverse transcription-polymerase chain reaction and
nucleotide sequencing methods.
Results: A total of 783 stool specimens collected from children with diarrhea, under 5 years of
age, attending an urban hospital in Xinjiang were tested for rotavirus antigen, and 398 (50.8%)
were positive. Overall, the most prevalent rotavirus genotype was G1P[8] (40.0%), followed by
G3P[8] (17.5%), G2P[4] (8.3%), and G2P[6] (6.5%). G1 rotavirus was the most prevalent genotype
until 2004. However, in 2005, G3 rotavirus (51.9%) became a dominating strain. Only one G9 strain
was isolated in this region (isolated for the first time in 1999) and it became a more prevalent
strain (21.2%) in 2005.
Conclusions: The results of this study are of importance to the decision makers in the evaluation
of rotavirus vaccines in China.
# 2008 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.* Corresponding author. Tel.: +32 16 332184; fax: +32 16 332131.
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Group A rotaviruses cause diarrhea in more than 125 million
infants and young children globally each year, resulting in
more than 600 000 deaths in children under 5 years of age.1 InPublished by Elsevier Ltd. All rights reserved.
e12 X.-L. Yang et al.China, an estimated 2.5 million children are infected,
230 000 are hospitalized, and 33 000 children die, annually
due to rotavirus infection.2,3 In previous studies carried out in
China, rotaviruses were found to be a major public health
threat for children.4—6 A literature review covering more
than two decades (1983—2005) indicated that a median of
44% of the hospitalized children with diarrhea were infected
with rotavirus.7
Rotaviruses belong to the Reoviridae and possess a gen-
ome of 11 segments of double-stranded RNA. The two outer
capsid proteins VP7 (specifying G genotypes) and VP4 (spe-
cifying P genotypes), elicit independently neutralizing
responses.8 Based on these proteins, a dual classification
system of group A rotaviruses has been introduced. Rota-
viruses can be genotyped by multiplex reverse transcrip-
tion-polymerase chain reaction (RT-PCR), or by sequence
analysis of different gene segments. So far, at least 15 G and
27 P genotypes have been described in humans and a variety
of mammalian and avian species.8—13 The major human G
genotypes, which account for more than 80% of the rota-
virus gastroenteritis episodes worldwide, are G1, G2, G3,
G4, and G9, combined with the P genotypes, P[8], P[4], and
P[6].14—17
The four main genotypes, G1—G4, have been the predo-
minant strains in most parts of China.18—21 During 1997—2001,
G1 rotaviruses (55.3% to 89.5%) were detected frequently, but
G3 rotaviruses became highly prevalent in the following
years.19,22—25 A study conducted in the city of Wuhan during
2000—2006, reported about 86%G3P[8] strains in patientswith
diarrhea.6G9 rotavirus strains,whichare nowglobally thefifth
most important rotavirus genotype, are still an uncommon
rotavirus genotype in China.26 A study conducted between
1998 and 2004, identified only 45 G9 strains (3.4%) from four
out of nine regions of the country.27 Atypical strains have also
been reported rarely, even though a remarkable proportion of
the Chinese rotavirus strains has been untypeable.7
Xinjiang, Uyghur autonomous region, is the largest poli-
tical subdivision in the People’s Republic of China. It accounts
for more than one sixth of China’s total territory. Although
rotavirus strain diversity has been evaluated in many parts of
China, very little is known regarding the incidence of rota-
virus and strain diversity in the less developed far west area
of the country. In the present study, rotavirus strains isolated
from stool specimens of children under 5 years of age with
diarrhea in Xinjiang were genotyped to elucidate their geno-
mic diversity in this region.
Methods
Sample collection
Urumqi is the capital city of Xinjiang and has a population of
approximately 3 million. The People’s Hospital of Xinjiang is
one of the two general hospitals in the city. About 5000
patients with diarrhea attend the hospital each year, of
whom approximately 300 are hospitalized. Since 1996, the
Laboratory of Virology, Xinjiang Pediatric Institute, has
undertaken rotavirus diagnosis on stool samples from diar-
rhea patients attending the hospital. In the present study,
stool specimens were collected from children under 5 years
of age with diarrhea, from 1996 to 2005. Due to a fire disaster
in 2000, the Xinjiang Pediatric Institute moved to a tempor-ary site for two years, and therefore fewer samples were
collected during 2000—2002.
Rotavirus antigen detection
Stool specimens were tested for VP6 group A rotavirus anti-
gen, using an enzyme immunoassay kit provided by the
Lanzhou Institute of Biological Products (Lanzhou, Gansu,
People’s Republic of China). An aliquot of a fecal suspension
was added to a plastic microtiter well coated with a mono-
clonal antibody directed against the rotavirus group-specific
antigen VP6. The solution was incubated simultaneously with
an anti-rotavirus monoclonal antibody conjugated to horse-
radish peroxidase, resulting in the rotavirus antigen being
sandwiched between the solid-phase and the enzyme-linked
antibodies. After 30 min of incubation at 37 8C, the wells
were washed to remove unbound enzyme-labeled antibodies.
Urea peroxide and tetramethylbenzidine were added as
substrates and incubated for 10 min at 37 8C. The enzymatic
reaction that converts the colorless substrate to a blue color
was stopped with 1 N H2SO4, and the absorbance was deter-
mined spectrophotometrically.
The rotavirus antigen positive stool samples were trans-
ported to the Laboratory of Clinical and Epidemiological
Virology, Rega Institute, University of Leuven, Belgium, for
further molecular characterization.
RT-PCR
RNAwas extracted from the stool suspension using the QIAamp
Viral RNA mini kit (Qiagen/Westburg, Leusden, The Nether-
lands) according to the manufacturer’s instructions. RT-PCR
was carried out using the Qiagen OneStep RT-PCR kit (Qiagen/
Westburg). VP7 and VP4 geneswere amplifiedwith Beg9—End9
and Con2—Con3 primers, respectively, as previously
described.28,29 The reaction was carried out with an initial
reverse transcription step at 45 8C for 30 min and an activation
step at 95 8C for 15 min, followed by 35 cycles of amplification
(30 s at 94 8C, 30 s at 50 8C, 1 min at 72 8C), and a final
extension of 7 min at 72 8C in a thermal cycler.
Nucleotide sequencing
The PCR products were purified with the QIA quick PCR
purification kit (Qiagen/Westburg), and sequenced in both
directions, using the dideoxynucleotide chain termination
method with the ABI PRISM1 BigDye Terminator Cycle
Sequencing Reaction kit (Perkin-Elmer Applied Biosystems,
Foster City, CA, USA) on an automated sequencer (ABI
PRISMTM 3100). The consensus primers Beg9—End9 and
Con2—Con3 were used to amplify and sequence VP7 and
VP4 genes, respectively.
Multiplex RT-PCR
Type-specific oligonucleotide primers (for G genotypes, G1,
G2, G3, G4, and G9 and P genotypes, P[4], P[6], P[8], P[11],
and P[9]) were used.28 PCR products were run on a 2%
polyacrylamide gel, stained with ethidium bromide, and
visualized under UV light. Specific segment sizes for different
G and P genotypes were observed on stained gels.
Table 1 Distribution of stool specimens positive for rota-
virus in Xinjiang, China, 1996—2005




1996 65 31 47.7
1997 142 73 51.4
1998 86 39 45.3
1999 160 75 46.9
2000 17 15 88.2
2001 17 11 64.7
2002 5 3 60
2003 41 23 56.1
2004 93 47 50.5
2005 157 81 51.6
Total 783 398 50.8
Rotavirus strain distribution, China, 1996—2005 e13DNA and protein sequence analysis
The chromatogram sequencing files were examined using
Chromas 2.23 (Technelysium, Queensland, Australia), and
consensus sequences were prepared using SeqMan II (DNAS-
TAR, Madison, WI, USA). Nucleotide and amino acid sequence
similarity searches were performed using the National Center
for Biotechnology Information (NCBI, National Institutes of
Health, Bethesda, MD, USA) BLAST (Basic Local Alignment
Search Tool) server on GenBank database, release 153.0.30
Multiple sequence alignments were calculated using CLUS-
TALX 1.81.31 Sequences were editedmanually in the GeneDoc
version 2.6.002 alignment editor.32
DNA sequence submission
The nucleotide sequences described in this paper were sub-
mitted to GenBank using the National Center for Biotechnol-
ogy Information (NCBI, Bethesda, MD, USA) Sequin, version
6.15 under accession numbers DQ321492—DQ321497;
EU131101—EU131108.
Results
Detection of group A rotaviruses
Between January 1996 and December 2005, a total of 783
stool specimens were collected from children under 5 years
of age with diarrhea. Among them, 682 (87.1%) were col-
lected from in-patients. The stool samples were tested for
VP6 rotavirus antigen by enzyme immunoassay (EIA) and 398
(50.8%) were positive (Table 1). Nearly 80% of the patients
were less than 1 year old and 96%were less than 2 years of age
(Figure 1).
Distribution of G and P genotypes
A sufficient quantity of stool specimen was available for 321
EIA-positive children. G and P genotyping were carried out
on stool samples by using nucleotide sequencing and type-
specific primer based multiplex RT-PCR, which could detect
G genotypes G1, G2, G3, G4, and G9 and P genotypes P[8],
P[4], P[6], P[9], and P[11]. During our study period, four
globally important G genotypes (G1, G2, G3, G9) and three P
genotypes (P[4], P[6], P[8]) were identified. The most pre-
valent genotype was G1P[8] (40.0%), followed by G3P[8]Figure 1 Age distribution of rotavirus-positiv(17.5%), G2P[4] (8.3%), and G2P[6] (6.5%) (Table 2). Unex-
pectedly, G4 rotavirus, a common strain in other parts of
China, was not identified in this study. G1, G3, and G9 were
found in combination mainly with the P[8] specificity, which
constituted 60% of the circulating strains. In contrast, P[4]
(12.3%) and P[6] (8.9%) specificities combined mostly with
G2 strains. Unusual G—P combinations, such as G1P[4],
G1P[6], G2P[8], G3P[4], G3P[6], and G9P[4], were also
detected. A remarkable proportion of samples (13.8%) con-
sisted of mixed infections, where G1 and G3 strains were the
most frequent cause.
Strong genotype fluctuations over time were observed
during the 10-year study period. The overall distribution of
the major genotypes over time is shown in Figure 2. Although
G1 strains were the most predominant genotype throughout
the study period, they decreasedmarkedly in 2001, 2003, and
2005. On the other hand, G3 strains were less prevalent
before 2001, but increased in 2001 and 2003, and reached
51.9% in 2005. Most interestingly, only one G9 strain com-
bined with P[6] was isolated in Xinjiang; this was isolated for
the first time in 1999 and became more prevalent (21.2%) in
2005. Most of the G9 strains isolated in 2005 were combined
with the P[8] specificity.
Partial amino acid sequences of the VP7 proteins of all G3
strains from Xinjiang and other parts of China available in
GenBank were analyzed. When compared with the prototype
Chinese G3 strains, the Xinjiang-G3 strains showed two aminoe children in Xinjiang, China, 1996—2005.
Table 2 Distribution of G and P genotypes of rotavirus strains in Xinjiang, China, 1996—2005
Rotavirus strains Number (%) of rotavirus G/P genotypes
1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 Total
G1P[4] 1 (3.7) 3 (4.8) 1 (2.6) 3 (4.3) 0 0 0 0 3 (11.5) 0 11 (3.4)
G1P[8] 8 (29.6) 47 (75.8) 20 (51.3) 25 (35.7) 3 (21.4) 1 (11.1) 1 (33.3) 10 (43.5) 11 (42.3) 4 (7.7) 130 (40.0)
G1P[X] 0 0 1 (2.6) 8 (11.4) 0 0 0 1 (4.3) 4 (15.4) 1 (1.9) 15 (4.6)
G2P[4] 8 (29.6) 1 (1.6) 0 10 (14.3) 1 (7.1) 1 (11.1) 0 0 2 (7.7) 4 (7.7) 27 (8.3)
G2P[6] 6 (22.2) 6 (9.7) 0 2 (2.9) 6 (42.9) 1 (11.1) 0 0 0 0 21 (6.5)
G3P[8] 1 (3.7) 1 (1.6) 8 (20.5) 9 (12.6) 0 3 (33.3) 0 8 (34.8) 2 (7.7) 25 (48.1) 57 (17.5)
G9P[6] 0 0 0 1 (1.4) 0 0 0 0 2 (7.7) 3 (5.8) 6 (1.8)
G9P[8] 0 0 0 0 0 0 0 0 0 7 (13.5) 7 (2.2)
G/P mixed 3 (11.1) 4 (6.5) 9 (23.0) 9 (12.6) 4 (28.6) 3 (33.3) 2 (66.7) 4 (17.4) 2 (7.7) 5 (9.6) 45 (13.8)
Others 0 0 0 3 (4.3) 0 0 0 0 0 3 (5.8) 6 (1.8)
Total 27 62 39 70 14 9 3 23 26 52 325
e14 X.-L. Yang et al.acid substitutions, Asp96Asn and Asp213Asn, in the antigenic
regions A and C, respectively (Figure 3). These amino acid
changes are believed to be critical for rotavirus strain to
escape host immunity.
Discussion
Many studies have been conducted in China to examine the
burden of rotavirus disease. Most studies have documented a
high frequency of rotavirus infections (27—62%) among chil-Figure 3 Alignment of antigenic regions A and C of VP7 proteins of C
indicate the identical amino acids with the strain CH-32.
Figure 2 Temporal changes in the distribution of the majodren with gastroenteritis.4,7 The present study demonstrated
that rotavirus caused diarrhea in 50.8% of the children under
5 years of age who attended a regional hospital in China.
Thus, the rotavirus detection rate in our study is comparable
to other Asian countries such as Thailand, Japan, Myanmar,
Indonesia, Malaysia, and Vietnam (50—65%),33—38 but much
higher than reported from India, Bangladesh, South Korea,
and Hong Kong (20—30%).39—42
Five G genotypes (G1—G4, G9) are the most common
rotaviruses worldwide, and the distributions of rotavirushinese G3 rotavirus strains. Positions 96 and 213 are shaded. Dots
r rotavirus G genotypes in Xinjiang, China, 1996—2005.
Rotavirus strain distribution, China, 1996—2005 e15types are changing over time.16 In Xinjiang, G1 rotaviruses
were the predominant strains for a long time, but recently G3
strains have become the dominant genotype (Figure 2). It was
found that G3 strains constituted only 9% of the circulating
strains during 1996—2000, but increased in 2001 (33.3%),
2003 (34.8%), and 2005 (48.1%) (Table 2). In contrast, G1
strains were responsible for 53% of the infections during
1996—2000, but they decreased to 11.1% in 2001 and to
7.7% in 2005.
In an attempt to answer the question of why G3 strains
have become one of the predominant rotavirus strains in
China, Trinh and colleagues43 suggested that the emergence
of G3 strains could be due to some amino acid substitutions in
the VP7 proteins. They compared the VP7 proteins of Chinese
G3 strains (isolated between 1986 and 1992) with the corre-
sponding proteins from G3 strains isolated recently, and
hypothesized that two amino acid substitutions, Asp96Asn
and Asp213Asn (critical positions to react with neutralizing
antibodies) in antigenic regions A and C, respectively, could
be responsible for escaping host immunity. Similar amino acid
substitutions were also identified in the VP7 genes of all
Xinjiang-G3 strains isolated during our study period
(Figure 3). The suggestion that these amino acid changes
are responsible for the recent emergence of G3 strains in
China is not supported by the findings, since similar substitu-
tions have occurred in all G3 strains in this study during 1996—
2005, but they did not emerge before 2001. The possibility of
involvement of gene segments other than VP7 cannot be
excluded. Therefore, sequence analyses of other gene seg-
ments are required to reveal the cause of the emergence of
G3 strains in China.
G9 rotaviruses have been emerging since 1995, and have
become one of the important rotavirus genotypes in many
countries.44 However, in many areas of China, surprisingly,
G9 strains have not become established as a common strain.
For example, a study conducted in Wuhan during 2000—
2006 identified only one G9 strain.6 Another study isolated
G9 strains (4%) in only three out of the six sentinel sites
during 2001—2003.4 Nevertheless, consistent detection of
G9 strains has been reported outside mainland China, such
as in Taiwan and Hong Kong.45,46 In the present study, we
detected 21.2% G9 strains in 2005, although only three
strains were identified before 2004. The first G9 strain with
P[6] specificity was detected in 1999. However, the major-
ity of the G9 strains identified in 2005 contained P[8]
specificity. It is possible that the initial G9P[6] strain under-
went some reassortment events with the local strains con-
taining the P[8] specificity. By acquiring the most common
P[8] specificity, G9P[8] strains might be better adapted to
infect the human host, and become an emerging strain in
Xinjiang.
Recently, G12 rotaviruses have been detected in many
Asian countries including India, Bangladesh, Nepal, Thailand,
Japan, and Korea.42,47—51 However, G12 rotaviruses have not
been reported in China including Xinjiang thus far. Strikingly,
uncommon genotypes were not detected during the 10-year
study period in Xinjiang, although a remarkable proportion of
the samples were found to be reassortants with unusual VP7—
VP4 combinations and mixed infections.
Two rotavirus vaccines RotaTeqTM and RotarixTM have
been licensed in more than 100 countries,52 but they have
not been tested yet in China. A lamb-derived monovalent(G10P[12]) live-attenuated oral vaccine LLR, developed by
the Lanzhou Institute of Biological Products, was licensed in
China in 2000, and is being used in parts of China
(www.who.int/vaccine_research/diseases/diarrhoeal/en/
index5.html). The vaccine is reported to induce neutralizing
antibody responses in 60% of the vaccinated children in
clinical trials, but has not been licensed internationally.
Recently, a collaboration between the Program for Appro-
priate Technology in Health (PATH) and the Wuhan Institute
of Biological Products (WIBP) has been launched to manu-
facture a human—bovine reassortment rotavirus vaccine in
China (www.path.org/projects/rotavirus_vaccine.php). To
implement an effective vaccine, geographical variation of
the prevalent strains must be taken into account.14,15,53
Furthermore, it should also be noted that the prevailing
genotypes differ considerably from one season to the next,
even within the same geographical area. Therefore, our
findings, regarding rotavirus strain diversity in Xinjiang over
a 10-year period will be important for the decision makers in
evaluating the currently licensed vaccine in China, and in
considering the need for other vaccines.
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